Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小鱼完成签到 ,获得积分10
5秒前
拓小八完成签到,获得积分0
7秒前
7秒前
arniu2008应助初景采纳,获得30
8秒前
东风应助科研通管家采纳,获得30
13秒前
cssc完成签到,获得积分10
13秒前
东风应助科研通管家采纳,获得30
13秒前
东风应助科研通管家采纳,获得30
13秒前
XU博士完成签到,获得积分10
18秒前
花花子完成签到 ,获得积分10
18秒前
303完成签到 ,获得积分10
30秒前
yeeja完成签到 ,获得积分10
30秒前
boymin2015完成签到 ,获得积分10
33秒前
英俊落雁完成签到 ,获得积分10
33秒前
枫威完成签到 ,获得积分10
34秒前
36秒前
41秒前
123完成签到 ,获得积分10
41秒前
小青年儿完成签到 ,获得积分0
43秒前
超越俗尘发布了新的文献求助10
44秒前
47秒前
ly完成签到 ,获得积分10
48秒前
55秒前
55秒前
友好的牛排完成签到,获得积分0
56秒前
fengwei完成签到,获得积分10
58秒前
RaeganWehe完成签到,获得积分10
1分钟前
Gaara0504完成签到,获得积分10
1分钟前
1分钟前
1分钟前
白白不喽完成签到 ,获得积分10
1分钟前
tough_cookie完成签到 ,获得积分10
1分钟前
科研通AI6.4应助Gaara0504采纳,获得10
1分钟前
zhang完成签到 ,获得积分10
1分钟前
MadysonKotrba完成签到,获得积分10
1分钟前
QAQSS完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
puritan完成签到 ,获得积分10
1分钟前
cy__完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
化工安全与环保 1000
Autoparametric Resonance in Mechanical Systems 1000
基于锂离子电池正极材料回收的绿色溶剂开发及工程化应用研究 800
Effects of Two Weeks of Red Light Therapy on Choroidal Thickness and Axial Length in Young Adults 700
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 600
Management and the Arts 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7656682
求助须知:如何正确求助?哪些是违规求助? 9227321
关于积分的说明 19828972
捐赠科研通 7223019
什么是DOI,文献DOI怎么找? 3280333
关于科研通互助平台的介绍 2440621
邀请新用户注册赠送积分活动 2280175